Abstract
Background
Mutations in cardiac ion channel genes have been identified to cause sudden unexplained deaths (SUD), and polymorphisms have also been suggested to be risk factors. Therefore, postmortem genetic testing has become an important tool in elucidating the cause of death.
Methods and results
In a sudden death case, a LQT-3-associated mutation (Il768V) in the cardiac sodium channel gene SCN5A was detected beside the common polymorphism H558R which is known to mitigate the effect of mutations in the gene. Both sequence variations were heterozygous. Large number of intervening base pairs make it impossible to identify whether they were located in cis or trans. Functional consequences of both variants were characterized after expressing different cRNAs in Xenopus oocytes by voltage clamp measurements. Western blot analysis indicates that the cis configuration of both variants may lead to a null allele. Since the woman had received an injection of Ultracain®, the potential effect of this drug was tested. In a trans configuration of both variants, the mutant channel exhibited an increase susceptibility of at least 10% for blocking with the drug articaine. Another novel finding is that the midpoint of activation in the case of the mutant channel is leftward shifted of at least −10 mV.
Conclusion
The results of the study suggest that postmortem molecular screening is an important tool to elucidate the cause of SUD and that the administration of a drug and a functional interaction between polymorphisms and ion channel mutations may trigger the risk for sudden death.
Similar content being viewed by others
References
Liberthson RR (1996) Sudden death from cardiac causes in children and young adults. N Engl J Med 34:1039–1044
Chugh SS (2000) Sudden cardiac death with apparently normal hearts. Circulation 102:649–654
Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO (1996) Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA 276:199–204
Corrado D, Basso C, Thiene G (2001) Sudden cardiac death in young people with apparently normal heart. Cardiovasc Res 50:399–408
Morentin B, Suarez-Mier MP, Aguilera B (2003) Sudden unexplained death among persons 1–35 years old. Forensic Sci Int 135:213–217
Puranik R, Chow CK, Duflou JA, Kilborn MJ, McGuire MA (2005) Sudden death in the young. Heart Rhythm 2:1277–1282
Wever EF, de Medina EO Robles (2004) Sudden death in patients without structural heart disease. J Am Coll Cardiol 43:1137–1144
Ackerman MJ (2004) Cardiac channelopathies: it’s in the genes. Nat Med 10:463–464
Tester DJ, Ackerman MJ (2007) Postmortem long QT syndrome genetic testing for sudden unexplained death in the young. J Am Coll Cardiol 49:240–246
Priori SG, Napolitano C, Giordano U, Collisani G, Memmi M (2000) Brugada syndrome and sudden cardiac death in children. Lancet 355:808–809
Ackerman MJ, Tester DJ, Driscoll DJ (2001) Molecular autopsy of sudden unexplained death in the young. Am J Forensic Med Pathol 22:105–111
Laitinen P, Fodstad H, Piippo K, Swan H, Toivonen L, Viitasalo M, Kaprio J, Kontula K (2000) Survey of the coding region of the HERG gene in long QT syndrome reveals six novel mutations and an amino acid polymorphism with possible phenotyic effects. Hum Mut 15:50–581
Peolzing S, Forleo C, Samodell M, Dudash L, Sorrentiono S, Anaclerio M, Troccoli R, Iacoviello M, Romito R, Guida P, Chahine M, Pitzalis M, Deschenes I (2006) SCN5A polymorphism restores trafficking of a Brugada syndrome mutation on a separate gene. Circulation 114:368–376
Cheng J, Tester DJ, Tan BH, Valdivia CR, Kroboth S, Ye B, January CT, Ackerman MJ, Makielski JC (2011) The common African American polymorphism SCN5A-S1103Y interacts with mutation SCN5A-R680H to increase late Na current. Physiol Genomics 43:461–466
Viswanathan PC, Benson DW, Balser JR (2003) A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation. J Clin Inverst 111:341–346
Splawski I, Shen J, Timothy KW BS, Lehmann MH, Priori S, Robinson JL, Moss AJ, Schwartz PJ, Towbin JA, Vincent GM, Keating MT (2000) Spectrum of mutations in long QT-syndrome genes: KVLQT1, HERG, SCN5A, KCNE1 and KCNE2. Circulation 102:1178–1185
Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparin M, DeSimone L, Coltorti F, Bloise R, Keegan R, Cruz Filho FES, Vignati G, Benatar A, DeLogu A (2006) Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycarida. Circulation 106:69–74
Lu CW, Lin JH, Rajawat YS, Jerng H, Rami TG, Sanchez X, DeFreitas G, Carabello B, DeMayo F, Kearney DL, Miller G, Pfaffinger PJ, Bowles NE, Khoury DS, Towbin JA (2006) Functional and clinical Characterization of a mutation in KCNJ2 associated with Andersen–Twail syndrome. J Med Genet 43:653–659
Tiso N, Stephan DA, Nava A, Bagattin A, Devaney JM, Stanchi F, Larderet G, Brahmbhatt B, Brown K, Bauce B, Murgiago M, Basso C, Thiene G, Danieli GA, Rampazzo A (2001) Identification of mutations in the cardiac ryanodin receptor gene families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 10:189–194
Liman ER, Tytgat J, Hess P (1992) Subunit stoichiometry of a mammalian K + channel determined by construction of multimeric cDNAs. Neuron 9:861–71
Bradford MM (1976) A rapid and sensitive for the quantisation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72:248–254
Hersh EV, Giannakopoulos H, Levin LM, Secreto S, Moore PA, Peterson C, Hucheson M, Bouhajib M, Mosenkis A, Townsend RR (2006) The pharmacokinetics and cardiovascular effects of high-dose articaine with 1: 100000 and 1:1200000 epinephrine. JADA 137:1562–1571
Groenewegen AW, Bezzina C, von Tintelen P, Hoorntje TM, Mannens MMAM, Wilde AAM, Jongsma HJ, Rook MB (2003) A novel LQT3 mutation implicates the human cardiac sodium channel domain IVS6 in inactivation kinetics. Cardiovasc Res 57:1072–1078
Rivota I, Clancy CE, Tateyama HL, Priori SG, Kass RS (2002) A novel SCN5A mutation associated with long QT-3: altered inactivation kinetics and channel dysfunction. Physiol Genomics 10:191–197
Iwasa H, Itoh T, Nagai R, Nakamura Y, Tanaka T (2000) Twenty single nucleotide polymorphisms (SNPs) and their allelic frequencies in four genes that are responsible for familial long QT syndrome in the Japanese population. J Hum Genet 45:182–183
Yang P, Kanki H, Drolet B, Yang T, Wei J, Viswanathan PC, Hohnloser SH, Shimizu W, Schwartz PJ, Stanton M, Murray KT, Norris K, Georges AL Jr, Roden DM (2002) Allelic variants in long-QT disease genes in patients with drug-associated torsades des point. Circulation 105:1943–1948
Tester DJ, Spoon DB, Valdivia HH, Makielski JC, Ackermann MJ (2004) Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner´s cases. Mayo Clin Proc 79:1380–1384
Tester DJ, Ackermann MJ (2005) Sudden infant death syndrome: how significant are the cardiac channelopathies? Cardiovasc Res 67:388–396
Saunders AM, Trowers MK, Shimkets RA, Blakemore S, Crowther DJ, Mansfield TA, Wallace DM, Strittmatter WJ, Roses AD (2000) The role of apolipoprotein E and Alzheimer´s disease; pharmacogenomic target selection. Biochim Biophys Acta 1502:85–94
Daley GQ, Cargill M (2001) The heart SNPs a beat: polymorphism in candidate genes for cardiovascular diseases. Trends Cardiovasc Med 11:60–66
Roses AD (2000) Pharmacogenetics and the practice of medicine. Nature 405:857–865
Acknowledgments
We would like to thank R.G. Kallen for providing the hNav1.5 clone and S.C. Cannon for the hbeta1 subunit. This work was supported by the following grants (to JT): G.0257.08 and G.0330.06 (FWO-Vlaanderen), OT-05-64 (K.U.Leuven), and UA P6/31 (Interuniversity Attraction Poles, Belgian Science Policy).
Ethical standards
All experiments comply with laws.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kauferstein, S., Kiehne, N., Peigneur, S. et al. Cardiac channelopathy causing sudden death as revealed by molecular autopsy. Int J Legal Med 127, 145–151 (2013). https://doi.org/10.1007/s00414-012-0679-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00414-012-0679-5